Contents
Issue 161 • January 2026
In association with
In Depth
Biopharma’s 2025 M&A boom
High-value oncology deals drive China’s drug licensing boom
AI takes charge of data, but challenges linger
In a Honduran city, biotechs create gene therapy cocktails to fight ageing
APAC’s rising stars beyond China
ASH 2025: AbbVie and Genmab’s Epkinly sets new standard in second-line FL